Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment-Reference-Cited by-同舟云学术

Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

Published:2023-09 Issue: Volume:203 Page:122-127
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Rivera-Caravaca José Miguel^ORCID,Anguita Sanchez Manuel,Sanmartín Fernández Marcelo,Rafols Carles,Barón-Esquivias Gonzalo,Arribas Ynsaurriaga Fernando,Freixa-Pamias Román,Lekuona Goya Iñaki,Vázquez Rodríguez José Manuel,Pérez-Cabeza Alejandro I.,Cosín-Sales Juan,Ureña Montilla Isabel,Álvarez-Vieitez Blanco Antonio,Marín Francisco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Stroke prevention strategies in high-risk patients with atrial fibrillation;Kotalczyk;Nat Rev Cardiol,2021

2. Atrial fibrillation and stroke;Essa;Card Electrophysiol Clin,2021

3. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options;Jankowski;Circulation,2021

4. Pathophysiology of atrial fibrillation and chronic kidney disease;Ding;Cardiovasc Res,2021

5. Renal disease and atrial fibrillation;Stefil;Card Electrophysiol Clin,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study;Thrombosis Journal;2024-07-17

2. Balancing the Risks of Stroke and Bleeding in Patients With Atrial Fibrillation and Renal Dysfunction;JACC: Advances;2024-04

3. Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study;2024-01-03

4. Vascular protection with rivaroxaban in the comprehensive management of atrial fibrillation;Expert Review of Cardiovascular Therapy;2023-11-02

5. Research Progress in Bleeding Caused by Rivaroxaban in Patients with Atrial Fibrillation;Advances in Clinical Medicine;2023